Protective Effects of Ghrelin on Ischemia/Reperfusion Injury in the Isolated Rat Heart

Lin Chang, Yongsheng Ren, Xiuhua Liu, Wei Gen Li, Jinghui Yang, Bin Geng, Neal L. Weintraub, Chaoshu Tang

Research output: Contribution to journalArticle

142 Citations (Scopus)

Abstract

Ghrelin, an endogenous ligand of the growth hormone secretagogue receptor, has been reported to have beneficial effects on cardiac function. The authors used the Langendorff model of ischemia/reperfusion (I/R) injury in isolated rat heart to determine whether ghrelin exerts direct cardioprotective effects. Also, the capacity of ghrelin to bind to sarcolemmal membrane fractions before and after ischemia and reperfusion was examined. Compared with vehicle administration, administration of ghrelin (100-10,000 pM) during the reperfusion period resulted in improvement in coronary flow, heart rate, left ventricular systolic pressure, and left ventricular end-diastolic pressure. Ghrelin also enhanced the rates of left ventricular contraction and relaxation after ischemia following reperfusion. Administration of ghrelin during reperfusion reduced myocardial release of lactate dehydrogenase and myoglobin, indicating protection against cardiomyocyte injury. In addition, ghrelin attenuated the depletion of myocardial ATP resulting from ischemia and reperfusion. A receptor-binding assay demonstrated that maximum binding capacity of ghrelin to sarcolemmal membranes was significantly increased after ischemia and was further increased after I/R. However, Scatchard analysis showed that the affinity of ghrelin for its receptor was not altered. The authors have concluded that administration of ghrelin during reperfusion protects against myocardial I/R injury. The cardioprotective effects are independent of growth hormone release and likely involve binding to cardiovascular receptors, a process that is upregulated during I/R.

Original languageEnglish (US)
Pages (from-to)165-170
Number of pages6
JournalJournal of Cardiovascular Pharmacology
Volume43
Issue number2
DOIs
StatePublished - Feb 1 2004
Externally publishedYes

Fingerprint

Ghrelin
Reperfusion Injury
Reperfusion
Ischemia
Ghrelin Receptor
Blood Pressure
Myocardial Reperfusion Injury
Myocardial Reperfusion
Membranes
Myoglobin
Ventricular Pressure
L-Lactate Dehydrogenase
Cardiac Myocytes
Growth Hormone
Myocardial Ischemia
Adenosine Triphosphate
Heart Rate
Ligands
Wounds and Injuries

Keywords

  • Ghrelin
  • Ghrelin receptor
  • Heart
  • Ischemia/reperfusion

ASJC Scopus subject areas

  • Pharmacology
  • Cardiology and Cardiovascular Medicine

Cite this

Protective Effects of Ghrelin on Ischemia/Reperfusion Injury in the Isolated Rat Heart. / Chang, Lin; Ren, Yongsheng; Liu, Xiuhua; Li, Wei Gen; Yang, Jinghui; Geng, Bin; Weintraub, Neal L.; Tang, Chaoshu.

In: Journal of Cardiovascular Pharmacology, Vol. 43, No. 2, 01.02.2004, p. 165-170.

Research output: Contribution to journalArticle

Chang, Lin ; Ren, Yongsheng ; Liu, Xiuhua ; Li, Wei Gen ; Yang, Jinghui ; Geng, Bin ; Weintraub, Neal L. ; Tang, Chaoshu. / Protective Effects of Ghrelin on Ischemia/Reperfusion Injury in the Isolated Rat Heart. In: Journal of Cardiovascular Pharmacology. 2004 ; Vol. 43, No. 2. pp. 165-170.
@article{a1c6c67f629948c4b7d1e7c226bda8d3,
title = "Protective Effects of Ghrelin on Ischemia/Reperfusion Injury in the Isolated Rat Heart",
abstract = "Ghrelin, an endogenous ligand of the growth hormone secretagogue receptor, has been reported to have beneficial effects on cardiac function. The authors used the Langendorff model of ischemia/reperfusion (I/R) injury in isolated rat heart to determine whether ghrelin exerts direct cardioprotective effects. Also, the capacity of ghrelin to bind to sarcolemmal membrane fractions before and after ischemia and reperfusion was examined. Compared with vehicle administration, administration of ghrelin (100-10,000 pM) during the reperfusion period resulted in improvement in coronary flow, heart rate, left ventricular systolic pressure, and left ventricular end-diastolic pressure. Ghrelin also enhanced the rates of left ventricular contraction and relaxation after ischemia following reperfusion. Administration of ghrelin during reperfusion reduced myocardial release of lactate dehydrogenase and myoglobin, indicating protection against cardiomyocyte injury. In addition, ghrelin attenuated the depletion of myocardial ATP resulting from ischemia and reperfusion. A receptor-binding assay demonstrated that maximum binding capacity of ghrelin to sarcolemmal membranes was significantly increased after ischemia and was further increased after I/R. However, Scatchard analysis showed that the affinity of ghrelin for its receptor was not altered. The authors have concluded that administration of ghrelin during reperfusion protects against myocardial I/R injury. The cardioprotective effects are independent of growth hormone release and likely involve binding to cardiovascular receptors, a process that is upregulated during I/R.",
keywords = "Ghrelin, Ghrelin receptor, Heart, Ischemia/reperfusion",
author = "Lin Chang and Yongsheng Ren and Xiuhua Liu and Li, {Wei Gen} and Jinghui Yang and Bin Geng and Weintraub, {Neal L.} and Chaoshu Tang",
year = "2004",
month = "2",
day = "1",
doi = "10.1097/00005344-200402000-00001",
language = "English (US)",
volume = "43",
pages = "165--170",
journal = "Journal of Cardiovascular Pharmacology",
issn = "0160-2446",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Protective Effects of Ghrelin on Ischemia/Reperfusion Injury in the Isolated Rat Heart

AU - Chang, Lin

AU - Ren, Yongsheng

AU - Liu, Xiuhua

AU - Li, Wei Gen

AU - Yang, Jinghui

AU - Geng, Bin

AU - Weintraub, Neal L.

AU - Tang, Chaoshu

PY - 2004/2/1

Y1 - 2004/2/1

N2 - Ghrelin, an endogenous ligand of the growth hormone secretagogue receptor, has been reported to have beneficial effects on cardiac function. The authors used the Langendorff model of ischemia/reperfusion (I/R) injury in isolated rat heart to determine whether ghrelin exerts direct cardioprotective effects. Also, the capacity of ghrelin to bind to sarcolemmal membrane fractions before and after ischemia and reperfusion was examined. Compared with vehicle administration, administration of ghrelin (100-10,000 pM) during the reperfusion period resulted in improvement in coronary flow, heart rate, left ventricular systolic pressure, and left ventricular end-diastolic pressure. Ghrelin also enhanced the rates of left ventricular contraction and relaxation after ischemia following reperfusion. Administration of ghrelin during reperfusion reduced myocardial release of lactate dehydrogenase and myoglobin, indicating protection against cardiomyocyte injury. In addition, ghrelin attenuated the depletion of myocardial ATP resulting from ischemia and reperfusion. A receptor-binding assay demonstrated that maximum binding capacity of ghrelin to sarcolemmal membranes was significantly increased after ischemia and was further increased after I/R. However, Scatchard analysis showed that the affinity of ghrelin for its receptor was not altered. The authors have concluded that administration of ghrelin during reperfusion protects against myocardial I/R injury. The cardioprotective effects are independent of growth hormone release and likely involve binding to cardiovascular receptors, a process that is upregulated during I/R.

AB - Ghrelin, an endogenous ligand of the growth hormone secretagogue receptor, has been reported to have beneficial effects on cardiac function. The authors used the Langendorff model of ischemia/reperfusion (I/R) injury in isolated rat heart to determine whether ghrelin exerts direct cardioprotective effects. Also, the capacity of ghrelin to bind to sarcolemmal membrane fractions before and after ischemia and reperfusion was examined. Compared with vehicle administration, administration of ghrelin (100-10,000 pM) during the reperfusion period resulted in improvement in coronary flow, heart rate, left ventricular systolic pressure, and left ventricular end-diastolic pressure. Ghrelin also enhanced the rates of left ventricular contraction and relaxation after ischemia following reperfusion. Administration of ghrelin during reperfusion reduced myocardial release of lactate dehydrogenase and myoglobin, indicating protection against cardiomyocyte injury. In addition, ghrelin attenuated the depletion of myocardial ATP resulting from ischemia and reperfusion. A receptor-binding assay demonstrated that maximum binding capacity of ghrelin to sarcolemmal membranes was significantly increased after ischemia and was further increased after I/R. However, Scatchard analysis showed that the affinity of ghrelin for its receptor was not altered. The authors have concluded that administration of ghrelin during reperfusion protects against myocardial I/R injury. The cardioprotective effects are independent of growth hormone release and likely involve binding to cardiovascular receptors, a process that is upregulated during I/R.

KW - Ghrelin

KW - Ghrelin receptor

KW - Heart

KW - Ischemia/reperfusion

UR - http://www.scopus.com/inward/record.url?scp=1642581469&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1642581469&partnerID=8YFLogxK

U2 - 10.1097/00005344-200402000-00001

DO - 10.1097/00005344-200402000-00001

M3 - Article

C2 - 14716201

AN - SCOPUS:1642581469

VL - 43

SP - 165

EP - 170

JO - Journal of Cardiovascular Pharmacology

JF - Journal of Cardiovascular Pharmacology

SN - 0160-2446

IS - 2

ER -